CV
CapsoVision, Inc. (NASDAQ)
Healthcare — Medical Devices
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.
Price History
Fundamentals
| Market Cap | $368.23M |
| P/E Ratio (TTM) | - |
| Forward P/E | - |
| EPS (TTM) | $-1.06 |
| Dividend Yield | - |
| Profit Margin | -198.87% |
| Revenue Growth | 0.30% |
| ROE | -185.09% |
| Debt/Equity | 3.90 |
| Recommendation | None |
| Analyst Target | $10.00 |
| Analysts | 1 |
| Indexes | NASDAQ |
Technical Indicators
| RSI (14) | 52.1 |
| Beta | - |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $15.37 |
| 52-Week Low | $3.43 |
| 50-Day Avg | $6.87 |
| 200-Day Avg | $6.42 |
| Avg Volume | 149.8K |
| Volume | 161.3K |
Performance Analysis
NEUTRALCV presents a mixed picture with both positive and negative indicators.
Recent News
Last updated: Jul 02, 2026 13:05 UTC
Back to Screener Export Report